SCHEMBL30474348

SCHEMBL30474348

Fc1cc(CBr)c(F)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.39
KDM1B Q8NB78 1/20 0.39
GPR84 Q9NQS5 1/20 0.37
ALDH1A1 P00352 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HTR2A P28223 9/20 0.33
HTR2C P28335 8/20 0.33
HTR2B P41595 6/20 0.33
SLC6A4 P31645 1/20 0.33
KCNH2 Q12809 1/20 0.33
DPP4 P27487 1/20 0.32
MAPT P10636 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2C9 P11712 2/20 0.31
PLA2G1B P04054 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
ATG4B Q9Y4P1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL377235 1.00 KDM1A (0.39) KDM1AKDM1BGPR84ALDH1A1TDP1
SCHEMBL31266184 0.91 GPR84 (0.37) KDM1AKDM1BGPR84ALDH1A1TDP1
SCHEMBL693457 0.91 GPR84 (0.37) KDM1AKDM1BGPR84ALDH1A1TDP1
SCHEMBL11027502 0.88 GPR84 (0.36) KDM1AKDM1BGPR84ALDH1A1TDP1
SCHEMBL3875287 0.88 GPR84 (0.38) KDM1AKDM1BGPR84ALDH1A1TDP1
SCHEMBL488821 0.86 GPR84 (0.37) KDM1AKDM1BGPR84ALDH1A1TDP1
SCHEMBL18226969 0.84 DPP4 (0.39) DPP4
SCHEMBL14774772 0.83 DPP4 (0.33) KDM1AKDM1BGPR84DPP4MAPT
SCHEMBL30030017 0.83 DPP4 (0.33) KDM1AKDM1BGPR84DPP4MAPT
SCHEMBL3363763 0.82 KDM1A (0.38) KDM1AKDM1BGPR84ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4605394-A1 PYRIMIDINE SGC STIMULATORS Tisento Therapeutics Inc. (US) 2025-08-27 EP disclosed
EP-4582420-A1 MDM2/MDMX DOUBLE-TARGET INHIBITOR COMPOUND, PRODRUG, PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF Global Health Drug Discovery Institute (CN) 2025-07-09 EP disclosed
WO-2025064534-A1 SUBSTITUTED AMINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE DEEP APPLE THERAPEUTICS, INC. (US) 2025-03-27 WO disclosed
CN-119343339-A Heterocyclic GLP-1 agonists 加舒布鲁姆生物公司 2025-01-21 CN disclosed
EP-4469444-A1 HETEROCYCLIC GLP-1 AGONISTS Gasherbrum Bio, Inc. (US) 2024-12-04 EP disclosed
WO-2024086179-A1 PYRIMIDINE SGC STIMULATORS TISENTO THERAPEUTICS, INC. (US) 2024-04-25 WO disclosed
WO-2023138684-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO , INC. (US) 2023-07-27 WO disclosed